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C holangiocarcinoma is rising in clinical imporr r tance because of its increasing incidence, subr r optimal response to therapy, and poor prognor r sis. Recent investigations into the underlying molecular mechanisms involved in cholangiocarcinogenesis and tumor growth have contributed greatly to our underr r standing of this disease. 1, 2 Conversion from normal to malignant bile epithelium probably requires a stepwise accumulation of successive genetic abnormalities inr r volving a variety of molecular defects of both oncogenes and tumor suppressor genes. However, the molecular pathogenesis of cholangiocarcinoma is still largely unr r known.
The guanine nucleotiderbinding proteins (G pror r teins) play a key role in cell signaling. Its b and g subr r unit control the signals involved in cell growth. The Gr g7 gene is widely distributed in the signal transduction pathways, and Grg7 rcoupled G proteins may contribr r ute to carcinogenesis in many cancers. 3r5 Several studr r ies have found a downrregulated Grg7 gene in gastror r intestinal tract cancers, including esophageal, gastric, pancreatic, and colorectal cancers. To our knowledge, the expression of Grg7 hasn't been confirmed in extrar hepatic cholangiocarcinoma. In this study, we evaluated the expression of Grg7 in 21 extrarhepatic cholangior r carcinoma (EHCC) patients. The expression of Grg7 was also compared among cancer tissues, perircancerr r ous normal bile duct tissue, and normal bile duct tisr r sues. The association of Grg7 and the histological grade of EHCC were also investigated.
METHODS
Twentyrone patients (14 male, 7 female) with disr r tal EHCC who underwent surgery at the Changhai Hospital, Shanghai Second Military Medical Universtiy, were studied. Mean age was 58.8 years. All patients unr r original research report g-prOTein gaMMa 7
Hematol Oncol Stem Cell Ther 3(2) Second Quarter 2010 hemoncstem.edmgr.com derwent pancreaticoduodenectomy (Whipple procer r dure) for primary tumors not associated with primary sclerosing cholangitis. After the surgery, the tumor and corresponding nonrtumor tissues were immedir r ately frozen in liquid nitrogen and stored at -80ºC until use. Pericancerous normal bile duct tissue was taken from the area within 2 cm from the edge of canr r cer. Normal bile duct tissue was taken from the area at least 5 cm away from the edge of cancer. Clinical staging: 10 patients were stage IrII, 11 patients were stage IrII. The study has approved by the Specialty Committee on Ethics of Biomedicine, the Second Military Medical University.
RNA extraction and real time reverse stranscription (RT)sPCR analysis
Tissue samples were taken immediately after surgery and stored at -80ºC. RNA was extracted using the TRIzol reagent (TaKaRa Bio Inc. Japan) according to the manufacturer's recommendations. The RNA was dissolved to 1(g/µL using diethylpyrocarbonater treated water and stored at -80ºC until use.
Primer sequence was designed according to pubr r lished mRNA sequences of Grg7 gene (GenBank ID: NMr016373: 128bp 5'rTGTCAGCCACTAACAT AGCCCAGGCCCGGAAGCTGGTGGAACAG CTACGCATAGAAGCCGGGATTGAGCGCA TCAAGGTCTCCAAAGCGGCGTCTGACCT CATGAGCTACTGTGAGCAACATGCCr3'). The oligonucleotide primer pairs for Grg7 were synr r thesized (ShengGong Inc, China) (Sense primer: 5'r TGTCAGCCACTAACAACATAGCr3'; antisense primer: 5'rGGCATGTTGCTCACAGTAGCr3' ).
Grg7 mRNA extracted from 100mg tissues was prepared using the RNeasy Kit (Huashun, China), followed by reverse transcription into cDNA with oligordT primers (Takara Bio Inc, Japan). PCR was conducted in GeneAmp PCR system 2400 (GeneAmp, USA). A reaction mix of 40 µL was prer r pared, incubated at 42ºC for 60min, reacted at 70ºC for 6min and then denatuated of reverse transcriptase. PCR was performed, in a total mix of 1 µL cDNA, dNTP, forward and reverse primers, and Taq polyr r merase (TakaRa Bio Inc, Japan). Positive and negative controls were included in all runs. The PCR was perr r formed using a method described previously.
Standard recombinant plasmid preparation: PCR product was cloned into the pMD18rT vecr r tor (Takara Bio Inc, Japan). The clones were inocur r lated into 100 µL Escherichia coli DH5a competent cells. White colonies were selected and screened by PCR. Briefly, white colonies were picked, incubated in Amp+ LB broth overnight at 37°C, 200 rpm/min. Plasmid DNA were extracted and purified according to recommendation of manufacturer (miniBest plasr r mid purification kit Ver 2.0, Takara Bio Inc, Japan). Followed by PCR amplification and agarose gel visur r alizing, the concentration of plasmid DNA was calcur r lated as 251.4 ng/µL. The plasmid DNA was diluted as 10r2, 10r3, 10r4, 10r5, 10r6 ng/µL to be used as standard benchmark.
Real time RTrPCR: PCR reactions containing SYBRrgreen were amplified on a Corbett Real Time PCR machine (Roche Diagonostics, USA). The 20 µL Tag reaction mix included Grg7 forward and rer r verse primers and 1 µL standard plasmid or tissue. Realrtime quantification of cDNA was performed. Lingtcycler Version 5.32 was run to analyze the par r rameters to calculate the original concentration of the template. Immunohistochemistry Staining All tissue samples for immunohistochemical staining were fixed in buffered formalin, and embedded in parr r affin, and cut into 5¼mrthick slices. Prior to antirGg7 immunostaining, endogenous peroxidase activity was blocked with 3% H 2 O 2 in water for 10 min. Heatrinr r duced epitope retrieval was performed with 1.0 mM EDTA buffer pH 8.0 for 10 min in a microwave oven followed by a 20rmin cooling down. In order to block nonspecific antibody binding, tissue samples were incubated with 10% goat serum in PBS for 30 min. Primary polyclonal rabbit Grg7 antibody was used at a 1:50 dilution overnight at 4ºC. Rabbit serum used as an isotype control at similar concentrations. This was followed by incubation with Envision HRP lar r beled polymer conjugated to goatrantirrabbit immur r noglobulins (Dako) for 30 min at room temperature.
Staining development was performed with DAB with timed monitoring using a positive control sample. The slides were then counterstained with hematoxylin, der r hydrated, cleared, and mounted. These sections were read by a pathologist. The clinicalpathological data variables were availr r able for evaluation. The data were compared between Grg7rpositive and Grg7rnegative patients. Spearman (nonparametric) correlation was used to correlate Grg7 expression with age, gender, tumor histological grade, tumor stage and the status of preoperative her r patic function. Fisher's exact test was used in data nur r meration. The Frtest was used in data measurement. The basic significance level was at P<.05 and all data was analyzed using SPSS statistical software (Version 11.0; SPSS Inc., Chicago, IL).
RESULTS
The histological grading of extrarhepatic cholangiocarr r cinoma was as follows: 6 patients were Grade I (well differentiated); 6 were Grade II (moderately differenr r tiated), and 9 were Grade III (poorly differentiated).
Gg 7 mRNA expression
EHCC samples expressed Grg7 mRNA at significantr r ly lower levels than perircancerous bile duct tissues and normal bile duct tissues. The average level of Gr g7 mRNA was 1.9000±0.8317×10 r6 ng/µL in EHCC tissues, 3.5920±0.8125×10 r6 ng/µL in perircancerr r ous bile duct tissues, and 3.4799±0.4463r6 ng/µL in normal bile duct tissue samples (Tables 1, 2 ). Patient demographic information and histological grading are presented in Table 1 .
Immunohistochemical staining
As shown in Figure 1 , cells from five normal bile duct tissues have strong expression of cytoplasmic protein.
In 21 primary EHCC tissues analyzed by immunor r histochemistry staining, Grg7 was weakly or moderr r ately expressed in 10 of the EHCC tissue samples. The positivity was linked to the tumor cells. Eleven EHCC samples had a negative staining of cytoplasmic protein (Figure 2 ). The negativity expression rate was original research report g-prOTein gaMMa 7 52.38% among EHCC tissue samples. Moreover, for these 11 negative samples, 1 was from a wellrdifferenr r tiated EHCC (1/6, 16.67%), 2 were from moderately differentiated EHCC (2/6, 33.33%), and 8 were from poorly differentiated EHCC (8/9, 88.89%).
Gsg 7 mRNA expression and clinicopathological data
The clinicopathological features analyzed in relar r tion to the Grg7 expression status are given in Table  3 . Spearman analysis found that expression of Grg7 mRNA had a significant correlation with histological grading. The correlation coefficients were -0.911 and -0.506, respectively (P<.0001 and P=.008, respecr r tively). There was no significant correlation between Grg7 expression and host factors such as age, gender, clinical staging or the status of preoperative hepatic function (P>.05). Grg7 expression was significantly lower in poorly differentiated EHCC than in moderr r ately and wellrdifferentiated EHCC tissues (P<.05).
DISCUSSION
The identification of the change of gene expression in tumor tissues and nonrtumor tissues is fundamental for understanding its biological mechanisms. G pror r teins are essential molecules in signal transduction pathways. Studies showed that Grg7 has specific regur r latory effects on adenylate cyclase signal transduction, 6 may stimulate receptor nucleotide exchange, 7 and plays an important role in intracellular signal transduction and controls growth signals in cells. Downrregulation of Grg7 has been proved in several digestive organ cancers. In the present study, we studied the expresr r sion of Grg7 and its clinical significance in EHCC.
Intrahepatic cholangiocarcinoma (IHCC) and exr r trahepatic cholangiocarcinoma are two closely related, but biologically unique neoplastic processes. This was supported by a prior study of methylation profiles of tumor suppressor genes in IHCC and EHCC. 8 Study also revealed that p27 expression decreased progresr r sively from proximal to distal in the biliary tree and correlated with locationrrelated differences in outr r come. Cyclin D1 and Bcl2 overexpression also varied in the bile duct tissue according to anatomic site. 9 In the present study, we demonstrated that the expresr r sion of Grg7 mRNA and its protein was strongly suppressed in EHCC tissues compared with normal bile duct tissues and perircancerous normal bile duct tissues. More than 50 per cent of EHCC tissues had a negative expression of Grg7 by immunohistochemir r cal study. The reduced expression of Grg7 was also confirmed by prior study in IHCC, 10 which indicate that Grg7 may be the key point in the pathogenesis of IHCC and EHCC, and IHCC and EHCC may partially share a common molecular pathogenesis. The decreased expression of Grg7 has also been confirmed in pancreatic, esophageal and colon cancer tissues, further support that this is a common phenomenon in the process of tumorgenesis. Reduced expression of Grg7 is also correlated with loss of heterozygosity (LOH) and reduced transduction of growth inhibir r tion signal with cell contact. 10r12 As a result, Grg7 has the potential to become the common target of genetic therapy to digestive tract cancers. In this study, we found that the expression of Grg7 mRNA was not associated with patient age, gender, and preoperative liver function, but was associated with histological staging of the cancer. The expression of Grg7 mRNA was significantly lower in poorly difr r ferentiated EHCC than in moderately differentiated EHCC (P=.001). There was also statistically signifir r cant difference of Gr_7 expression in moderately difr r ferentiated and well differentiated cholangiocarcinor r ma (P=.020). Decreased expression of Grg7 protein has also been found in poorly differentiated IHCC than in moderately differentiated IHCC. 10 Study has
